Tramadol-induced oral dryness and pilocarpine treatment: Effects on total protein and IgA

Archives of Oral Biology

Volumn 56, Issue 4, 2011, Pages 395-400

  Loostrom H ^a   Akerman S ^a   Ericson, D ^a   Tobin, G ^b   Gotrick B ^a  

^a MALMÖ UNIVERSITY   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Drug induced xerostomia; IgA; Pilocarpine; Randomized controlled trial; Total protein

Indexed keywords

IMMUNOGLOBULIN A; MUSCARINIC AGENT; NARCOTIC AGENT; PILOCARPINE; SALIVA PROTEIN; TRAMADOL;

ANALYSIS OF VARIANCE; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HUMAN; METABOLISM; RANDOMIZED CONTROLLED TRIAL; SALIVA; SALIVATION; SECRETION; XEROSTOMIA;

ANALYSIS OF VARIANCE; HUMANS; IMMUNOGLOBULIN A; MUSCARINIC AGONISTS; NARCOTICS; PILOCARPINE; SALIVA; SALIVARY PROTEINS AND PEPTIDES; SALIVATION; TRAMADOL; XEROSTOMIA;

EID: 79952988208     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2010.10.019     Document Type: Article

References (27)

1. H. Grad, M. Grushka, and L. Yanover Drug induced xerostomia. The effects and treatment J Can Dent Assoc 51 April(4) 1985 296 300
2. L.M. Sreebny, and S.S. Schwartz A reference guide to drugs and dry mouth - 2nd edition Gerodontology 14 July(1) 1997 33 47
3. Bahn S.L. Drug-related dental destruction Oral Surg Oral Med Oral Pathol 33 January(1) 1972 49 54
4. I.D. Mandel Sialochemistry in diseases and clinical situations affecting salivary glands Crit Rev Clin Lab Sci 12 4 1980 321 366
5. M.E. Brosky The role of saliva in oral health: strategies for prevention and management of xerostomia J Support Oncol 5 May(5) 2007 215 225 (Pubitemid 46860748)
6. P.C. Fox Salivary enhancement therapies Caries Res 38 May-June(3) 2004 241 246 (Pubitemid 38716216)
7. S.R. Porter, C. Scully, and A.M. Hegarty An update of the etiology and management of xerostomia Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97 January(1) 2004 28 46 (Pubitemid 38067257)
8. L. Berk Systemic pilocarpine for treatment of xerostomia Expert Opin Drug Metab Toxicol 4 October(10) 2008 1333 1340
9. B. Gotrick, S. Akerman, D. Ericson, R. Torstenson, and G. Tobin Oral pilocarpine for treatment of opioid-induced oral dryness in healthy adults J Dent Res 83 May(5) 2004 393 397 (Pubitemid 41766095)
10. P. Brandtzaeg Synthesis and secretion of secretory immunoglobulins: with special reference to dental diseases J Dent Res 55 April 1976 Spec No: C102-114
11. Y. Levy, M. Dueymes, Y.L. Pennec, Y. Shoenfeld, and P. Youinou IgA in Sjogren's syndrome Clin Exp Rheumatol 12 September-October(5) 1994 543 551 (Pubitemid 24323901)
12. S. Chaushu, E. Yefe Nof, A. Becker, J. Shapira, and G. Chaushu Parotid salivary immunoglobulins, recurrent respiratory tract infections and gingival health in institutionalized and non-institutionalized subjects with Down's syndrome J Intellect Disabil Res 47 February(Pt 2) 2003 101 107 (Pubitemid 36367498)
13. W. Teeuw, J.A. Bosch, E.C. Veerman, and A.V. Amerongen Neuroendocrine regulation of salivary IgA synthesis and secretion: implications for oral health Biol Chem 385 December(12) 2004 1137 1146 (Pubitemid 40103787)
14. D. Gutman, and H. Ben-Aryeh The influence of age on salivary content and rate of flow Int J Oral Surg 3 5 1974 314 317
15. T. Osterberg, S. Landahl, and B. Hedegard Salivary flow, saliva, pH and buffering capacity in 70-year-old men and women. Correlation to dental health, dryness in the mouth, disease and drug treatment J Oral Rehabil 11 March(2) 1984 157 170
16. D.A. Sack, P.K. Neogi, and M.K. Alam Immunobead enzyme-linked immunosorbent assay for quantitating immunoglobulin A in human secretions and serum Infect Immun 29 July(1) 1980 281 283 (Pubitemid 10086009)
17. D. Bratthall, and R.P. Ellen Determination of immunoglobulin A in saliva by immunobead enzyme-linked immunosorbent assay: comparison with single radial immunodiffusion J Clin Microbiol 16 October(4) 1982 766 769 (Pubitemid 12029317)
18. G.H. Carpenter, G.B. Proctor, L.E. Ebersole, and J.R. Garrett Secretion of IgA by rat parotid and submandibular cells in response to autonomimetic stimulation in vitro Int Immunopharmacol 4 August(8) 2004 1005 1014 (Pubitemid 38844175)
19. P. Brandtzaeg Human secretory immunoglobulins.VII. Concentrations of parotid IgA and other secretory proteins in relation to the rate of flow and duration of secretory stimulus Arch Oral Biol 16 November(11) 1971 1295 1310
20. P. Brandtzaeg Molecular and cellular aspects of the secretory immunoglobulin system APMIS 103 January(1) 1995 1 19
21. F.R. Korsrud, and P. Brandtzaeg Quantitative immunohistochemistry of immunoglobulin- and J-chain-producing cells in human parotid and submandibular salivary glands Immunology 39 February(2) 1980 129 140 (Pubitemid 10118120)
22. P. Brandtzaeg Synthesis and secretion of human salivary immunoglobulins J.R. Garrett, J. Ekström, L.C. Anderson, Glandular mechanisms of salivary secretion basel 1998 Karger 167 199
23. L. Eliasson, and A. Carlen An update on minor salivary gland secretions Eur J Oral Sci 118 October(5) 2010 435 442
24. B. Gotrick, and G. Tobin The xerogenic potency and mechanism of action of tramadol inhibition of salivary secretion in rats Arch Oral Biol 49 December(12) 2004 969 973 (Pubitemid 39366834)
25. G. Tobin Salivary secretion control M.D. Binder, N. Hirokawa, U. Windhorst, Encyclopedia of neuroscience 2008 Springer-Verlag Berlin, Heidelberg 3565 3571
26. T.L. Borella, L.A. De Luca Jr., D.S. Colombari, and J.V. Menani Central muscarinic receptor subtypes involved in pilocarpine-induced salivation, hypertension and water intake Br J Pharmacol 155 December(8) 2008 1256 1263
27. J.R. Garrett The proper role of nerves in salivary secretion: a review J Dent Res 66 February(2) 1987 387 397